Assessing the efficacy of male Wolbachia-infected mosquito deployments to reduce dengue incidence in Singapore: study protocol for a cluster-randomized controlled trial
This study will provide evidence from a multi-site, randomized controlled trial for the efficacy of IIT-SIT in reducing dengue incidence. The trial will provide valuable information to estimate intervention efficacy for this novel vector control approach and guide plans for integration into national vector control programs in dengue-endemic settings.Trial registrationClinicalTrials.gov, identifier:NCT05505682. Registered on 16 August 2022. Retrospectively registered. (Source: Trials)
Source: Trials - December 17, 2022 Category: Research Source Type: clinical trials
Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country
Condition: Malaria Interventions: Biological: SumayaVac-1(SUM-101); Biological: Verorab; Biological: CHMI Sponsors: Swiss Tropical & Public Health Institute; Ifakara Health Institute; Sumaya Biotech GmbH & Co. KG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2022 Category: Research Source Type: clinical trials
